These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27663085)

  • 1. Evidence-based pathology in its second decade: toward probabilistic cognitive computing.
    Marchevsky AM; Walts AE; Wick MR
    Hum Pathol; 2017 Mar; 61():1-8. PubMed ID: 27663085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited additive value of the Ki-67 proliferative index on patient survival in World Health Organization-classified pulmonary carcinoids.
    Swarts DR; Rudelius M; Claessen SM; Cleutjens JP; Seidl S; Volante M; Ramaekers FC; Speel EJ
    Histopathology; 2017 Feb; 70(3):412-422. PubMed ID: 27701763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours.
    Clay V; Papaxoinis G; Sanderson B; Valle JW; Howell M; Lamarca A; Krysiak P; Bishop P; Nonaka D; Mansoor W
    Clin Transl Oncol; 2017 May; 19(5):579-586. PubMed ID: 27848218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interobserver variability for the WHO classification of pulmonary carcinoids.
    Swarts DR; van Suylen RJ; den Bakker MA; van Oosterhout MF; Thunnissen FB; Volante M; Dingemans AM; Scheltinga MR; Bootsma GP; Pouwels HM; van den Borne BE; Ramaekers FC; Speel EJ
    Am J Surg Pathol; 2014 Oct; 38(10):1429-36. PubMed ID: 25046341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of CD44 and Orthopedia Homeobox Protein (OTP) Expression in Pulmonary Carcinoid Tumours.
    Papaxoinis G; Nonaka D; O'Brien C; Sanderson B; Krysiak P; Mansoor W
    Endocr Pathol; 2017 Mar; 28(1):60-70. PubMed ID: 27873160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis in pathology: Are we "prognosticating" or only establishing correlations between independent variables and survival? A study with various analytics cautions about the overinterpretation of statistical results.
    Marchevsky AM; Diniz MA; Manzoor D; Walts AE
    Ann Diagn Pathol; 2020 Jun; 46():151525. PubMed ID: 32353712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive pathological and clinical features of lung carcinoids with high proliferation index.
    Marchiò C; Gatti G; Massa F; Bertero L; Filosso P; Pelosi G; Cassoni P; Volante M; Papotti M
    Virchows Arch; 2017 Dec; 471(6):713-720. PubMed ID: 28631159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial intelligence in healthcare: past, present and future.
    Jiang F; Jiang Y; Zhi H; Dong Y; Li H; Ma S; Wang Y; Dong Q; Shen H; Wang Y
    Stroke Vasc Neurol; 2017 Dec; 2(4):230-243. PubMed ID: 29507784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
    Ács B; Zámbó V; Vízkeleti L; Szász AM; Madaras L; Szentmártoni G; Tőkés T; Molnár BÁ; Molnár IA; Vári-Kakas S; Kulka J; Tőkés AM
    Diagn Pathol; 2017 Feb; 12(1):20. PubMed ID: 28222768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IBM Watson Analytics: Automating Visualization, Descriptive, and Predictive Statistics.
    Hoyt RE; Snider D; Thompson C; Mantravadi S
    JMIR Public Health Surveill; 2016 Oct; 2(2):e157. PubMed ID: 27729304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grading the neuroendocrine tumors of the lung: an evidence-based proposal.
    Rindi G; Klersy C; Inzani F; Fellegara G; Ampollini L; Ardizzoni A; Campanini N; Carbognani P; De Pas TM; Galetta D; Granone PL; Righi L; Rusca M; Spaggiari L; Tiseo M; Viale G; Volante M; Papotti M; Pelosi G
    Endocr Relat Cancer; 2014 Feb; 21(1):1-16. PubMed ID: 24344249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External Validation of a Prognostic Model of Survival for Resected Typical Bronchial Carcinoids.
    Cattoni M; Vallières E; Brown LM; Sarkeshik AA; Margaritora S; Siciliani A; Imperatori A; Rotolo N; Farjah F; Wandell G; Costas K; Mann C; Hubka M; Kaplan S; Farivar AS; Aye RW; Louie BE
    Ann Thorac Surg; 2017 Oct; 104(4):1215-1220. PubMed ID: 28821334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma.
    Duregon E; Cappellesso R; Maffeis V; Zaggia B; Ventura L; Berruti A; Terzolo M; Fassina A; Volante M; Papotti M
    Hum Pathol; 2017 Apr; 62():1-7. PubMed ID: 27916625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?
    Pelosi G; Fabbri A; Cossa M; Sonzogni A; Valeri B; Righi L; Papotti M
    Semin Diagn Pathol; 2015 Nov; 32(6):469-79. PubMed ID: 26561395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary carcinoid and related tumours.
    Hasleton PS; Bostanci G
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():28-42. PubMed ID: 9337521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of PROM1 (CD133) confers poor prognosis in non-small cell lung cancer.
    Qiu ZX; Zhao S; Mo XM; Li WM
    Int J Clin Exp Pathol; 2015; 8(6):6589-95. PubMed ID: 26261540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
    Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W
    J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoid lung tumors--incidence, treatment and outcomes: a population-based study.
    Naalsund A; Rostad H; Strøm EH; Lund MB; Strand TE
    Eur J Cardiothorac Surg; 2011 Apr; 39(4):565-9. PubMed ID: 20888248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms.
    Kaemmerer D; Reimann C; Specht E; Wirtz RM; Sayeg M; Baum RP; Schulz S; Lupp A
    Oncotarget; 2015 Feb; 6(5):3346-58. PubMed ID: 25671300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis in lung carcinoid tumours. Is there a difference between atypical and typical carcinoids with and without metastasis?
    Sands TJ; Soomro IN; Chaudry ZR; Ronan J
    Histopathology; 2006 Dec; 49(6):653-4. PubMed ID: 17163851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.